Medica, one of the biggest medical technology trade fairs in the world, welcomes numerous international exhibitors and experts from the healthcare sector every year. Over 5,200 exhibitors will be present at this year’s edition, including several innovative Luxembourg companies that are advancing the frontiers of medical care.
The aim is to understand the market of IVD and medical device market.
Khalouche Cana, R&D and QA Manager at Abraca BioSystems, explains that the company can offer a flexible partnering model for the (co-) development and commercialisation of new solutions. It is part of the Luxembourg delegation this year. R&D Coordinator Schauli Frederic and QC Manager Borges Emilia will be present at the fair..
What does your company offer in the field of health technologies?
Abraca BioSystems serves the life sciences industry developing innovative technologies based on microporous silica-polymer membranes. In these applications, the membranes are used as matrix to graft chemical species onto silica to create activated or functionalised membrane.
Abraca BioSystems offers different partnering options for the (co-) development and commercialisation of new solutions.
Our products have practical applications in research labs, pharma and biotech manufacturing and diagnostics. There is an opportunity to solve complex separation and purification challenges with ion exchange membranes and affinity membranes. The matrix can be tailored to meet highly specific needs from demanding bio-based markets. They uniquely combine membrane technology, chromatographic properties and disposable usage in a single product.
What is the objective of your participation at Medica?
The aim is to understand the market of IVD and medical device market. With a flexible partnering model, Abraca BioSystems offers different partnering options for the (co-) development and commercialisation of new solutions.
What advantages does Luxembourg offer to companies in the healthtech field?
Luxembourg offers the opportunity to connect the various players in the healthech sector, and above all, to find a common interest between these companies.
Photo credit: Abraca BioSystems